RECURRENT SOLID TUMORS

Clinical trials for RECURRENT SOLID TUMORS explained in plain language.

Never miss a new study

Get alerted when new RECURRENT SOLID TUMORS trials appear

Sign up with your email to follow new studies for RECURRENT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First patients receive new experimental cancer drug in early safety trial

Disease control Recruiting now

This is a first-in-human study to test the safety, side effects, and best dose of a new investigational drug called RO7566802. It will be given alone and in combination with an existing immunotherapy drug (atezolizumab) to up to 250 adults with advanced solid tumors that have spr…

Matched conditions: RECURRENT SOLID TUMORS

Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control

Last updated Mar 20, 2026 14:47 UTC

RECURRENT SOLID TUMORS

Get alerted when new RECURRENT SOLID TUMORS trials appear

First patients receive new experimental cancer drug in early safety trial